更年期障害市場レポート：2023-2033
Menopause Market Report 2023-2033
レポート詳細
更年期障害市場レポート 2023-2033 ： 本レポートは、業界とその基礎となる力学をよりよく理解したい場合、新たな収益ポケットを目指す大手企業にとって貴重なものとなるでしょう。また... もっと見る
※上記価格は部署ライセンス（Departmental licence）価格です。
その他の価格についてはデータリソースまでお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。
サマリー
レポート詳細
更年期障害市場レポート 2023-2033： 本レポートは、業界とその基礎となる力学をよりよく理解したい場合、新たな収益ポケットを目指す大手企業にとって貴重なものとなるでしょう。また、異業種への進出や新地域での既存事業の拡大を目指す企業にとっても有益なレポートです。
高齢者人口の増加に伴う更年期障害治療薬の需要拡大
更年期障害および閉経後障害市場は、高齢化、意識の高まり、技術の進歩、医療費の増加などにより、革新的な新薬への需要が高まっています。更年期障害とその症状に対する認識が高まり、より多くの女性が治療の選択肢を求めるようになっています。高齢化社会は世界的に進行しており、今後数年間で更年期障害女性の数が増加すると予想されています。これは更年期障害治療薬にとって大きな市場機会となっています。
ライフスタイルの変化や座りがちな生活習慣により、不眠、不規則な気分の変化、ほてりなどの症状に悩まされる女性が増え、更年期障害の症状が増加しています。そのため、これらの症状を緩和する更年期障害治療薬の需要が高まっています。薬剤の製造や送達方法の新たな進歩により、副作用が少なく、より効果的で的を絞った更年期障害治療薬を作ることが可能になっています。さらに、世界的に医療費が増加するにつれて、より多くの女性が更年期障害治療薬を利用できるようになり、市場をさらに牽引することになるでしょう。
業界の成長を妨げる誤解と関連する副作用の課題
更年期障害は、しばしばタブー視され、十分な議論がなされていません。女性は、自分の症状について話すのが恥ずかしく、不快に感じ、オープンに治療を受けることに消極的になってしまうかもしれません。更年期障害に対するホルモン療法は、がんや心臓病のリスクを高めるなどの副作用があるため、患者の間で安全性への懸念が持たれています。さらに、更年期障害治療薬は高額であるため、購入できない女性もいます。また、健康保険が適用されない場合もあります。教育、製品の改良、価格戦略、戦略的マーケティングを通じてこれらの問題に対処することは、市場における更年期障害製品の成長を大きく後押しすることができます。
マーケットリサーチレポートを購入する前に、どのような質問をするべきか？
- 更年期障害市場はどのように進化しているのか？
- 更年期障害市場を牽引し、抑制しているものは何か？
- 更年期障害の各サブマーケットセグメントは予測期間中にどのように成長し、2033年にこれらのサブマーケットが占める売上はいくらになるのか？
- 2023年から2033年にかけて、更年期障害の各サブマーケットの市場シェアはどのように推移するのか？
- 2023年から2033年にかけて、市場全体の主な牽引役となるのは何か？
- 更年期障害の主要市場はマクロ経済のダイナミクスに広く追随するのか、それとも個々の国別市場が他を凌駕するのか？
- 2033年までに各国市場のシェアはどのように変化し、2033年に市場をリードするのはどの地域か？
- 主要プレイヤーは誰で、予測期間中の見通しはどうなっているのか？
- これらの主要企業の更年期障害プロジェクトは何か？
- 2023年から2033年の間に、業界はどのように進化していくのか？現在および今後10年間に行われる更年期障害のプロジェクトには、どのような意味があるのか？
- 更年期障害市場をさらに拡大するために、製品の商業化の必要性は高まっているのか？
- 更年期障害市場はどこに向かっているのか、そして市場の最前線に立つためにはどうすればよいのか？
- 新製品やサービスラインに対する最適な投資オプションは何か？
- 企業を新たな成長軌道に乗せ、C-suiteに移行させるための重要な展望は何か？
このことが、現在、そして今後10年間の更年期障害市場にどのような影響を与えるかを発見する必要があります：
- 253ページにわたる本レポートでは、109の表と154のチャート/グラフを独占的に提供します。
- 本レポートでは、業界における主要な収益性の高い分野を取り上げており、今すぐその分野をターゲットにすることができます。
- 世界、地域、国の売上高と成長率を詳細に分析しています。
- 競合他社が成功した主要なトレンド、変化、収益予測をハイライトしています。
本レポートは、今後10年間、更年期障害市場がどのように発展するか、またCOVID-19の景気後退やバウンスの変動に合わせて、今日あなたにお伝えします。この市場は、過去10年間のどの時点よりも、今が重要なのです。
2033年までの予測やその他の分析により、商業的な展望を明らかにする。
- 今回の調査では、2033年までの収益予測に加え、直近の実績、成長率、市場シェアも掲載しています。
- ビジネスの展望や展開など、独自の分析がご覧いただけます。
- 定性的分析（市場力学、促進要因、機会、阻害要因、課題など）、コスト構造、更年期障害価格上昇の影響、最近の動向などをご覧いただけます。
本レポートでは、COVID-19が業界や貴社にどのような影響を与えるかについて、データ分析および貴重な知見を提供しています。COVID-19の4つの回収パターン、すなわち「V」「L」「W」「U」の回収パターンとその影響について考察しています。
報告書の対象セグメント
治療タイプの見通し
・ダイエットサプリメント
・ OTC医薬品
- ホルモン剤
- 非ホルモン 抗うつ剤、その他
流通チャネル
- 小売
- オンライン
- 機関投資家向け販売
ステージ
- 閉経周辺期
- 更年期
- 更年期後
投与経路
- 外用薬
- 経口
- 注射剤
世界市場全体およびセグメントの収益予測に加え、5つの地域および18の主要国市場の収益予測も掲載しています：
北米
- アメリカ
- カナダ
欧州
- ドイツ
- 英国
- フランス
- スペイン
- イタリア
- ロシア
- その他の欧州地域
アジア太平洋地域
- 中国
- 日本
- インド
- オーストラリア
- 韓国
- その他のアジア太平洋地域
ラテンアメリカ
- ブラジル
- メキシコ
- アルゼンチン
- その他のラテンアメリカ地域
MEA
- GCC
- 南アフリカ
- その他のMEA地域
更年期障害市場の主要企業の一部について、2023年から2033年までのプロファイルと、これらの企業の事業のこのセグメントに焦点を当て、含まれています。
主要企業と市場成長の可能性
・ Abbott
・ AbbVie Inc.
・ Bayer AG
・ Cipla Inc.
・ Eli Lily
・ Emcure
・ Glenmark Pharmaceuticals Limited
・ Merck
・ Novartis
・ Novo Nordisk
・ Padagis
・ Pure Encapsulations, LLC
・ Teva Pharmaceuticals Limited
・ Theramex
・ TherapeuticsMD
更年期障害市場の世界全体の収益、金額ベースで2023年から2033年まで市場は2023年に173.3億米ドルを突破すると、私たちの仕事は計算されます。2033年まで収益が大きく伸びることが予測されます。当社の調査では、最も大きな可能性を秘めた企業を特定しています。彼らの能力、進歩、商業的展望を発見することで、先手を打つことができます。
更年期障害市場、2023年から2033年までのレポートはどのように役立つのでしょうか？
250ページ以上のレポートをまとめると、以下のような知識を得ることができます：
- 更年期障害市場、2023年から2033年までの収益予測 治療タイプ、流通チャネル、ステージ、投与経路、それぞれ世界と地域レベルで予測 - 業界の展望を発見し、投資と収益のための最も有利な場所を見つけることができます。
- 5つの地域と18の主要国市場の2033年までの収益予測 - 北米、欧州、アジア太平洋、ラテンアメリカ、MEAの更年期障害市場、2023年から2033年の市場予測をご覧いただけます。また、米国、カナダ、メキシコ、ブラジル、アルゼンチン、ドイツ、フランス、英国、イタリア、ロシア、中国、インド、日本、韓国、オーストラリアなど著名な経済圏の市場も予測されています。
- 更年期障害市場に関わる主要企業15社の企業プロファイルを含む、既存企業および市場参入を目指す企業の展望（2023年〜2033年）。
独自の予測による定量・定性分析をご覧いただけます。私たちのレポートだけが持つ情報を入手し、貴重なビジネスインテリジェンスとして情報を得ることができます。
他にはない情報
私たちの新しいレポートがあれば、知識に遅れをとったり、チャンスを逃したりする可能性は低くなります。私たちの仕事が、あなたの調査、分析、意思決定にどのように役立つかをご覧ください。Visiongainの調査は、更年期障害市場、2023年から2033年、市場をリードする企業の商業分析を必要とするすべての人のためのものです。データ、トレンド、予測を見つけることができます。
ページTOPに戻る
目次
目次
1 レポートの概要
1.1 研究の目的
1.2 更年期障害市場の紹介
1.3 本レポートが提供するもの
1.4 本レポートを読むべき理由
1.5 本分析レポートが回答する主な質問は以下の通りです：
1.6 本レポートは誰のためのものか？
1.7 方法論
1.7.1 市場の定義
1.7.2 市場評価・予測手法
1.7.3 データの検証
1.7.3.1 プライマリーリサーチ
1.7.3.2 セカンダリーリサーチ
1.8 よくある質問(FAQ)
1.9 関連するVisiongainのレポート
1.10 Visiongainについて
2 エグゼクティブサマリー
3 市場の概要
3.1 キーファインディング
4 市場の概要
4.1 主要な調査結果
4.2 マーケットダイナミクス
4.2.1 市場促進要因
4.2.1.1 更年期障害に伴う血管運動症状の発生率は増加傾向にある
4.2.1.2 更年期障害治療への投資の増加
4.2.1.3 研究が進むにつれて、栄養補助食品の利点が明らかになりつつある
4.2.2 市場抑制要因
4.2.2.1 ホルモン療法に伴う副作用
4.2.2.2 研究開発活動の制限
4.2.3 市場の好機
4.2.3.1 スタートアップ企業には大きなチャンスがある
4.2.3.2 ストレスや流行のライフスタイルは女性の健康に悪影響を与えるため、更年期障害製品メーカーにはチャンスがある
4.3 COVID-19の影響度分析
4.4 ポーターのファイブフォース分析
4.4.1 サプライヤーパワー
4.4.2 バイヤーパワー
4.4.3 競合他社のライバル関係
4.4.4 代替品からの脅威
4.4.5 新規参入の脅威
4.5 PESTLE分析
5 更年期障害市場分析：治療別
5.1 主要な調査結果
5.2 治療区分の成長展望
5.3 更年期障害市場タイプ別シェア、2023年、2028年、2033年
5.4 ダイエタリーサプリメント
5.4.1 ダイエットサプリメントの地域別市場予測、2023年〜2033年（US$ Bn)
5.4.2 ダイエットサプリメントの地域別市場シェア、2023年〜2033年 (%)
5.5 OTCファーマ製品
5.5.1 OTC医薬品の地域別市場予測、2023-2033年 (US$ Bn)
5.5.2 OTC医薬品の地域別市場シェア、2023-2033年(%)
5.5.3 ホルモン剤
5.5.3.1 ホルモン剤の地域別市場予測、2023-2033年 (US$ Bn)
5.5.3.2 ホルモン剤の地域別市場シェア、2023-2033年(%)
5.5.4 ノンホルモン
5.5.4.1 非ホルモンの地域別市場予測、2023-2033年 (US$ Bn)
5.5.4.2 非ホルモン剤の地域別市場シェア、2023-2033年(%)
5.5.5 抗鬱剤
5.5.5.1 抗鬱剤の地域別市場予測、2023-2033年 (US$ Bn)
5.5.5.1.1 抗鬱剤の地域別市場シェア、2023年〜2033年 (%)
5.5.5.2 その他
5.5.5.2.1 その他の地域別市場予測、2023-2033年 (US$ Bn)
5.5.5.2.2 その他の地域別市場シェア、2023-2033年 (%)
6 更年期障害市場分析：流通チャネル別
6.1 主要な調査結果
6.2 流通チャネルセグメントの成長展望
6.3 流通チャネル別更年期障害市場シェア、2023年、2028年、2033年
6.4 小売
6.4.1 小売業の地域別市場予測、2023年〜2033年（US$ Bn)
6.4.2 小売市場地域別シェア、2023年～2033年(%)
6.5 機関投資家向け販売
6.5.1 地域別機関投資家向け販売市場予測、2023-2033年 (US$ Bn)
6.5.2 機関投資家向け売上高の地域別市場予測、2023-2033年(%)
6.6 オンライン
6.6.1 オンラインの地域別市場予測、2023-2033年 (US$ Bn)
6.6.2 オンライン市場地域別シェア、2023-2033年(%)
7 更年期障害市場分析：ステージ別
7.1 主要な調査結果
7.2 ステージ別セグメント成長展望
7.3 ステージ別更年期障害市場シェア、2023年、2028年、2033年
7.4 閉経周辺期
7.4.1 閉経周辺期の地域別市場予測、2023年〜2033年（US$ Bn)
7.4.2 閉経周辺期の地域別市場シェア、2023年〜2033年 (%)
7.5 更年期
7.5.1 更年期障害の地域別市場予測、2023-2033年 (US$ Bn)
7.5.2 更年期障害の地域別市場シェア、2023-2033年(%)
7.6 更年期後
7.6.1 更年期後の地域別市場予測、2023年-2033年（US$ Bn)
7.6.2 更年期後の地域別市場シェア、2023-2033年(%)
8 更年期障害市場分析：投与経路別
8.1 主要な調査結果
8.2 投与経路別セグメントの成長展望
8.3 更年期障害市場流通チャネル別シェア、2023年、2028年、2033年
8.4 外用剤
8.4.1 外用剤市場の地域別予測、2023年〜2033年（US$ Bn)
8.4.2 外用剤市場の地域別シェア、2023年〜2033年 (%)
8.5 注射剤
8.5.1 注射剤の地域別市場予測、2023年-2033年 (US$ Bn)
8.5.2 注射剤の地域別市場シェア、2023-2033年(%)
8.6 経口剤
8.6.1 経口剤の地域別市場予測、2023-2033年 (US$ Bn)
8.6.2 経口剤の地域別市場シェア、2023-2033年(%)
9 更年期障害市場分析：地域別
9.1 主要な調査結果
9.2 地域別市場規模の推定と予測
9.3 COVID-19の影響度分析： 回復シナリオ(V、U、W、L)
10 北米の更年期障害市場分析
10.1 主要な調査結果
10.2 北米の更年期障害市場魅力度指数
10.3 北米の更年期障害市場：国別、2022年、2027年、2032年（US$ Bn)
10.4 北米の更年期障害の国別市場規模推定と予測
10.5 北米の更年期障害の治療別市場規模推定と予測：
10.6 北米の更年期障害の流通チャネル別市場規模推定と予測
10.7 北米の更年期障害のステージ別市場規模推定と予測
10.8 北米の更年期障害の投与経路別市場規模推定と予測
10.9 米国の更年期障害市場分析
10.10 カナダ更年期障害の市場分析
11 欧州の更年期障害市場分析
11.1 主要な調査結果
11.2 欧州更年期障害市場魅力度指数
11.3 欧州更年期障害国別市場、2023年、2028年、2033年（US$ Bn)
11.4 欧州更年期障害の国別市場規模推定と予測
11.5 欧州更年期障害の治療別市場規模推定と予測
11.6 欧州更年期障害の流通チャネル別市場規模推定と予測
11.7 欧州更年期障害のステージ別市場規模推定と予測
11.8 欧州更年期障害の投与経路別市場規模推定と予測
11.9 イギリス更年期障害の市場分析
11.10 ドイツ更年期障害の市場分析
11.11 フランス更年期障害の市場分析
11.12 イタリア更年期障害の市場分析
11.13 スペイン更年期障害の市場分析
11.14 ロシア更年期障害市場分析
11.15 その他の欧州の更年期障害の市場分析
12 アジア太平洋地域の更年期障害市場分析
12.1 主要な調査結果
12.2 アジア太平洋地域の更年期障害市場魅力度指数
12.3 アジア太平洋地域の更年期障害国別市場、2023年、2028年、2033年（US$ Bn)
12.4 アジア太平洋地域の更年期障害の国別市場規模推定と予測
12.5 アジア太平洋地域の更年期障害の治療別市場規模推定と予測
12.6 アジア太平洋地域の更年期障害の流通チャネル別市場規模推定と予測
12.7 アジア太平洋地域の更年期障害のステージ別市場規模推定と予測
12.8 アジア太平洋地域の更年期障害の投与経路別市場規模推定と予測
12.9 日本更年期障害の市場分析
12.10 中国更年期障害の市場分析
12.11 インド更年期障害の市場分析
12.12 オーストラリア更年期障害の市場分析
12.13 韓国更年期障害の市場分析
12.14 その他のアジア太平洋地域の更年期障害の市場分析
13 ラテンアメリカの更年期障害市場分析
13.1 主要な調査結果
13.2 ラテンアメリカの更年期障害市場魅力度指数
13.3 ラテンアメリカの更年期障害市場：国別、2022年、2027年、2032年（US$ Bn)
13.4 ラテンアメリカ更年期障害国別市場規模推定と予測
13.5 ラテンアメリカ更年期障害の治療別市場規模推定と予測
13.6 ラテンアメリカ更年期障害の流通チャネル別市場規模推定と予測
13.7 ラテンアメリカ更年期障害のステージ別市場規模推定と予測
13.8 ラテンアメリカ更年期障害の投与経路別市場規模推定と予測
13.9 ブラジルの更年期障害の市場分析
13.10 メキシコ更年期障害の市場分析
13.11 アルゼンチン更年期障害の市場分析
13.12 その他のラテンアメリカの更年期障害の市場分析
14 MEAの更年期障害市場分析
14.1 主要な調査結果
14.2 MEAの更年期障害市場魅力度指数
14.3 MEAの更年期障害市場：国別、2022年、2027年、2032年（US$Bn)
14.4 MEAの更年期障害の国別市場規模推定と予測
14.5 MEAの更年期障害の治療別市場規模推定と予測
14.6 MEAの更年期障害の流通チャネル別市場規模推定と予測
14.7 MEAの更年期障害のステージ別市場規模推定と予測
14.8 MEAの更年期障害の投与経路別市場規模推定と予測
14.9 GCCの更年期障害の市場分析
14.10 南アフリカの更年期障害の市場分析
14.11 その他のMEA地域の更年期障害の市場分析
15 競合他社の状況
15.1 企業シェア分析
15.2 戦略的な展望
16 会社概要
16.1 Theramex
16.1.1 企業スナップショット
16.1.2 会社概要
16.1.3 製品ベンチマーク
16.1.4 戦略的な展望
16.2 AbbVie Inc.
16.2.1 企業スナップショット
16.2.2 会社概要
16.2.3 財務分析
16.2.3.1 純収益、2019-2021年
16.2.4 製品のベンチマーキング
16.2.5 戦略的な展望
16.3 Bayer AG
16.3.1 企業スナップショット
16.3.2 会社概要
16.3.3 財務分析
16.3.3.1 純収益、2018-2021年
16.3.4 製品のベンチマーキング
16.4 Cipla Inc.
16.4.1 企業スナップショット
16.4.2 会社概要
16.4.3 財務分析
16.4.3.1 純収益、2019-2022年
16.4.4 製品のベンチマーキング
16.4.5 戦略的な展望
16.5 TherapeuticsMD
16.5.1 企業スナップショット
16.5.2 会社概要
16.5.3 財務分析
16.5.3.1 純収入、2020-2021年
16.5.4 製品のベンチマーキング
16.5.5 戦略的な展望
16.6 Eli Lilly and Company
16.6.1 企業スナップショット
16.6.2 会社概要
16.6.3 財務分析
16.6.3.1 純収益、2019-2021年
16.6.4 製品ベンチマーキング
16.7 Emcure
16.7.1 企業スナップショット
16.7.2 会社概要
16.7.3 財務分析
16.7.3.1 純収入、2019-2021年
16.7.4 製品のベンチマーキング
16.8 Glenmark Pharmaceuticals Limited
16.8.1 企業スナップショット
16.8.2 会社概要
16.8.3 財務分析
16.8.3.1 純収益、2019-2022年
16.8.4 製品のベンチマーキング
16.8.5 戦略的な展望
16.9 Merck & Co., Inc.
16.9.1 企業スナップショット
16.9.2 会社概要
16.9.3 財務分析
16.9.3.1 純収益、2019-2021年
16.9.4 製品のベンチマーキング
16.10 Novartis AG
16.10.1 企業スナップショット
16.10.2 会社概要
16.10.3 財務分析
16.10.3.1 純収益、2020-2022年
16.10.4 製品のベンチマーキング
16.11 Novo Nordisk A/S
16.11.1 企業スナップショット
16.11.2 会社概要
16.11.3 財務分析
16.11.3.1 純収益、2019-2022年
16.11.4 製品のベンチマーキング
16.12 Pure Encapsulations, LLC
16.12.1 企業スナップショット
16.12.2 会社概要
16.12.3 製品ベンチマーキング
16.13 Padagis
16.13.1 カンパニー・スナップショット
16.13.2 会社概要
16.13.3 製品ベンチマーキング
16.14 Teva Pharmaceutical Industries Ltd.
16.14.1 カンパニー・スナップショット
16.14.2 会社概要
16.14.3 財務分析
16.14.3.1 純収益、2019-2021年
16.14.4 製品のベンチマーキング
16.14.5 戦略的な展望
16.15 Abbott
16.15.1 企業スナップショット
16.15.2 会社概要
16.15.3 財務分析
16.15.3.1 純収益、2019-2021年
16.15.4 製品のベンチマーキング
17 結論と提言
17.1 Visiongainからの結びの言葉
17.2 市場関係者への提言
ページTOPに戻る
図表リスト
表の一覧
Table 1 Menopause Market Snapshot, 2023 & 2033 (US$ Billion, CAGR %)
Table 2 Menopause Market by Region, 2023-2033 (US$ bn, AGR (%), CAGR (%)): “V” Shaped Recovery Scenario
Table 3 Menopause Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR(%)): “U” Shaped Recovery Scenario
Table 4 Menopause Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR(%)): “W” Shaped Recovery Scenario
Table 5 Menopause Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR(%)): “L” Shaped Recovery Scenario
Table 6 Dietary Supplements Market Forecast by Region, 2023-2033 (US$ billion, AGR%, CAGR %)
Table 7 OTC Pharma Products Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR %)
Table 8 Hormonal Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR %)
Table 9 Non-Hormonal Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR %)
Table 10 Anti-depressants Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR %)
Table 11 Others Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR %)
Table 12 Retail Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR %)
Table 13 Institutional Sales Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR %)
Table 14 Online Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR %)
Table 15 Perimenopause Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR %)
Table 16 Menopause Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR %)
Table 17 Post menopause Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR %)
Table 18 Topical Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR %)
Table 19 Injectable Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR %)
Table 20 Oral Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR %)
Table 21 Menopause Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR (%))
Table 22 Menopause Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR (%)): “V” Shaped Recovery Scenario
Table 23 Menopause Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR(%)): “U” Shaped Recovery Scenario
Table 24 Menopause Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR(%)): “W” Shaped Recovery Scenario
Table 25 Menopause Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR(%)): “L” Shaped Recovery Scenario
Table 26 North America Menopause Market Forecast by Country, 2023-2033 (US$ billion, AGR%, CAGR %)
Table 27 North America Menopause Market Forecast by Type, 2023-2033 (US$ billion, AGR%, CAGR %)
Table 28 North America Menopause Market Forecast by Distribution Channel, 2023-2033 (US$ billion, AGR%, CAGR%)
Table 29 North America Menopause Market Forecast by Stage, 2023-2033 (US$ billion, AGR%, CAGR%)
Table 30 North America Menopause Market Forecast by RoA, 2023-2033 (US$ billion, AGR%, CAGR%)
Table 31 U.S. Menopause Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR %)
Table 32 Canada Menopause Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR %)
Table 33 Europe Menopause Market Forecast by Country, 2023-2033 (US$ billion, AGR%, CAGR %)
Table 34 Europe Menopause Market Forecast by Type, 2023-2033 (US$ billion, AGR%, CAGR %)
Table 35 Europe Menopause Market Forecast by Distribution Channel, 2023-2033 (US$ billion, AGR%, CAGR%)
Table 36 Europe Menopause Market Forecast by Stage, 2023-2033 (US$ billion, AGR%, CAGR%)
Table 37 Europe Menopause Market Forecast by RoA, 2023-2033 (US$ billion, AGR%, CAGR%)
Table 38 UK Menopause Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR %)
Table 39 Germany Menopause Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR %)
Table 40 France Menopause Market Forecast, 2023-2033 (US$ Bn, AGR%, CAGR %)
Table 41 Italy Menopause Market Forecast, 2023-2033 (US$ Bn, AGR%, CAGR %)
Table 42 Spain Menopause Market Forecast, 2023-2033 (US$ Bn, AGR%, CAGR %)
Table 43 Russia Menopause Market Forecast, 2023-2033 (US$ Bn, AGR%, CAGR %)
Table 44 Rest of Europe Menopause Market Forecast, 2023-2033 (US$ Bn, AGR%, CAGR %)
Table 45 Asia Pacific Menopause Market Forecast by Country, 2023-2033 (US$ billion, AGR%, CAGR %)
Table 46 Asia Pacific Menopause Market Forecast by Type, 2023-2033 (US$ billion, AGR%, CAGR %)
Table 47 Asia Pacific Menopause Market Forecast by Distribution Channel, 2023-2033 (US$ billion, AGR%, CAGR%)
Table 48 Asia Pacific Menopause Market Forecast by Stage, 2023-2033 (US$ billion, AGR%, CAGR%)
Table 49 Asia Pacific Menopause Market Forecast by RoA, 2023-2033 (US$ billion, AGR%, CAGR%)
Table 50 Japan Menopause Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR %)
Table 51 China Menopause Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR%)
Table 52 India Menopause Market Forecast, 2023-2033 (US$ Bn, AGR%, CAGR %)
Table 53 Australia Menopause Market Forecast, 2023-2033 (US$ Bn, AGR%, CAGR %)
Table 54 South Korea Menopause Market Forecast, 2023-2033 (US$ Bn, AGR%, CAGR %)
Table 55 Rest of Asia Pacific Menopause Market Forecast, 2023-2033 (US$ Bn, AGR%, CAGR %)
Table 56 Latin America Menopause Market Forecast by Country, 2023-2033 (US$ billion, AGR%, CAGR %)
Table 57 Latin America Menopause Market Forecast by Type, 2023-2033 (US$ billion, AGR%, CAGR %)
Table 58 Latin America Menopause Market Forecast by Distribution Channel, 2023-2033 (US$ billion, AGR%, CAGR%)
Table 59 Latin America Menopause Market Forecast by Stage, 2023-2033 (US$ billion, AGR%, CAGR%)
Table 60 Latin America Menopause Market Forecast by RoA, 2023-2033 (US$ billion, AGR%, CAGR%)
Table 61 Brazil Menopause Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR %)
Table 62 Mexico Menopause Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR %)
Table 63 Argentina Menopause Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR %)
Table 64 Rest of Latin America Menopause Market Forecast, 2023-2033 (US$ Bn, AGR%, CAGR %)
Table 65 MEA Menopause Market Forecast by Country, 2023-2033 (US$ billion, AGR%, CAGR %)
Table 66 MEA Menopause Market Forecast by Type, 2023-2033 (US$ billion, AGR%, CAGR %)
Table 67 MEA Menopause Market Forecast by Distribution Channel, 2023-2033 (US$ billion, AGR%, CAGR%)
Table 68 MEA Menopause Market Forecast by Stage, 2023-2033 (US$ billion, AGR%, CAGR%)
Table 69 MEA Menopause Market Forecast by RoA, 2023-2033 (US$ billion, AGR%, CAGR%)
Table 70 GCC Menopause Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR %)
Table 71 South Africa Menopause Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR %)
Table 72 Rest of MEA Menopause Market Forecast, 2023-2033 (US$ Bn, AGR%, CAGR %)
Table 73 Strategic Outlook
Table 74 Theramex: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 75 Theramex: Product Benchmarking
Table 76 Theramex: Strategic Outlook
Table 77 Abbvie Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 78 AbbVie Inc.: Product Benchmarking
Table 79 AbbVie Inc.: Strategic Outlook
Table 80 Bayer AG.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 81 Bayer AG: Product Benchmarking
Table 82 Cipla Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 83 Cipla: Product Benchmarking
Table 84 Cipla: Strategic Outlook
Table 85 TherapeuticsMD.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 86 TherapeuticsMD: Product Benchmarking
Table 87 TherapeuticsMD: Strategic Outlook
Table 88 Eli Lilly and Company.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 89 Eli Lilly and Company: Product Benchmarking
Table 90 Emcure.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 91 Emcure: Product Benchmarking
Table 92 Glenmark Pharmaceuticals Limited.: Key Details, (MD, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 93 Glenmark Pharmaceuticals Limited: Product Benchmarking
Table 94 Glenmark Pharmaceuticals Limited: Strategic Outlook
Table 95 Merck & Co., Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 96 Merck & Co. Inc.: Product Benchmarking
Table 97 Novartis AG.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 98 Novartis.: Product Benchmarking
Table 99 Novo Nordisk A/S.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 100 Novo Nordisk.: Product Benchmarking
Table 101 Pure Encapsulations, LLC.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 102 Pure Encapsulations, LLC.: Product Benchmarking
Table 103 Pure Encapsulations, LLC.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 104 Padagis.: Product Benchmarking
Table 105 Teva Pharmaceuticals Limited.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 106 Teva Pharmaceuticals Limited: Product Benchmarking
Table 107 Teva Pharmaceuticals Limited: Strategic Outlook
Table 108 Abbott.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 109 Teva Pharmaceuticals Limited: Product Benchmarking
図の一覧
Figure 1 Menopause Market Segmentation
Figure 7 Menopause Market: Market Dynamics
Figure 8 COVID Impact Analysis: Menopause Market Recovery Scenarios
Figure 9 Menopause Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR (%)): “V” Shaped Recovery
Figure 10 Menopause Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR (%)): “U” Shaped Recovery
Figure 11 Menopause Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR (%)): “W” Shaped Recovery
Figure 12 Menopause Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR (%)): “L” Shaped Recovery
Figure 13 Menopause Market: Porter’s Five Forces Analysis
Figure 14 Menopause Market: PESTLE Analysis
Figure 15 Menopause Market Forecast by Type 2023, 2028, 2033 (Revenue, CAGR %)
Figure 16 Menopause Market Share Forecast by Treatment Type, 2023, 2028, 2033 (%)
Figure 17 Dietary Supplements Market Forecast by Region, 2023-2033 (US$ billion)
Figure 18 Dietary Supplements Market Share Forecast by Region, 2023-2033 (%)
Figure 19 OTC Pharma Products Market Forecast by Region, 2023-2033 (US$ billion)
Figure 20 OTC Pharma Products Market Share Forecast by Region, 2023-2033 (%)
Figure 21 Hormonal Market Forecast by Region, 2023-2033 (US$ billion)
Figure 22 Hormonal Market Share Forecast by Region, 2023-2033 (%)
Figure 23 Non-Hormonal Market Forecast by Region, 2023-2033 (US$ billion)
Figure 24 Non-Hormonal Market Share Forecast by Region, 2023-2033 (%)
Figure 25 Anti-depressants Market Forecast by Region, 2023-2033 (US$ billion)
Figure 26 Anti-depressants Market Share Forecast by Region, 2023-2033 (%)
Figure 27 Others Market Forecast by Region, 2023-2033 (US$ billion)
Figure 28 Others Market Share Forecast by Region, 2023-2033 (%)
Figure 29 Menopause Market Forecast by Distribution Channel 2023, 2028, 2033 (Revenue, CAGR %)
Figure 30 Menopause Market Share Forecast by Distribution Channels, 2023, 2028, 2033 (%)
Figure 31 Retail Market Forecast by Region, 2023-2033 (US$ billion)
Figure 32 Retail Market Share Forecast by Region, 2023-2033 (%)
Figure 33 Institutional Sales Market Forecast by Region, 2023-2033 (US$ billion)
Figure 34 Institutional Sales Market Share Forecast by Region, 2023-2033 (%)
Figure 35 Online Market Forecast by Region, 2023-2033 (US$ billion)
Figure 36 Online Market Share Forecast by Region, 2023-2033 (%)
Figure 37 Menopause Market Forecast by Stage 2023, 2028, 2033 (Revenue, CAGR %)
Figure 38 Menopause Market Share Forecast by Stage, 2023, 2028, 2033 (%)
Figure 39 Perimenopause Market Forecast by Region, 2023-2033 (US$ billion)
Figure 40 Perimenopause Market Share Forecast by Region, 2023-2033 (%)
Figure 41 Menopause Market Forecast by Region, 2023-2033 (US$ billion)
Figure 42 Menopause Institutional Sales Market Share Forecast by Region, 2023-2033 (%)
Figure 43 Post menopause Market Forecast by Region, 2023-2033 (US$ billion)
Figure 44 Post Menopause Market Share Forecast by Region, 2023-2033 (%)
Figure 45 Menopause Market Forecast by RoA 2023, 2028, 2033 (Revenue, CAGR %)
Figure 46 Menopause Market Share Forecast by RoA, 2023, 2028, 2033 (%)
Figure 47 Topical Market Forecast by Region, 2023-2033 (US$ billion)
Figure 48 Topical Market Share Forecast by Region, 2023-2033 (%)
Figure 49 Injectable Market Forecast by Region, 2023-2033 (US$ billion)
Figure 50 Injectable Market Share Forecast by Region, 2023-2033 (%)
Figure 51 Oral Market Forecast by Region, 2023-2033 (US$ billion)
Figure 52 Oral Market Share Forecast by Region, 2023-2033 (%)
Figure 53 Menopause Market Forecast by Region 2023 & 2033 (Revenue, CAGR %)
Figure 54 Menopause Market Share Forecast by Region 2023, 2028, 2033(%)
Figure 55 Menopause Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR (%))
Figure 56 Menopause Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR (%)): “V” Shaped Recovery
Figure 57 Menopause Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR (%)): “U” Shaped Recovery
Figure 58 Menopause Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR (%)): “W” Shaped Recovery
Figure 59 Menopause Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR (%)): “L” Shaped Recovery
Figure 60 North America Menopause Market Attractiveness Index
Figure 61 North America Menopause Market by Region, 2022, 2027 & 2032 (US$ billion)
Figure 62 North America Menopause Market Forecast by Country, 2023-2033 (US$ billion, AGR %)
Figure 63 North America Menopause Market Share Forecast by Country, 2023 & 2033 (%)
Figure 64 North America Menopause Market Forecast by Type, 2023-2033 (US$ billion, AGR %)
Figure 65 North America Menopause Market Share Forecast by Type, 2023 & 2033 (%)
Figure 66 North America Menopause Market Forecast by Distribution Channel, 2023-2033 (US$ billion, AGR %)
Figure 67 North America Menopause Market Share Forecast by Distribution Channel, 2023 & 2033 (%)
Figure 68 North America Menopause Market Forecast by Stage, 2023-2033 (US$ billion, AGR %)
Figure 69 North America Menopause Market Share Forecast by Stage, 2023 & 2033 (%)
Figure 70 North America Menopause Market Forecast by RoA, 2023-2033 (US$ billion, AGR %)
Figure 71 North America Menopause Market Share Forecast by RoA, 2023 & 2033 (%)
Figure 72 U.S. Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 73 Canada Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 74 Europe Menopause Market Attractiveness Index
Figure 75 Europe Menopause Market by Region, 2023, 2028 & 2033 (US$ billion)
Figure 76 Europe Menopause Market Forecast by Country, 2023-2033 (US$ billion, AGR %)
Figure 77 Europe Menopause Market Share Forecast by Country, 2023 & 2033 (%)
Figure 78 Europe Menopause Market Forecast by Type, 2023-2033 (US$ billion, AGR %)
Figure 79 Europe Menopause Market Share Forecast by Type, 2023 & 2033 (%)
Figure 80 Europe Menopause Market Forecast by Distribution Channel, 2023-2033 (US$ billion, AGR %)
Figure 81 Europe Menopause Market Share Forecast by Distribution Channel, 2023 & 2033 (%)
Figure 82 Europe Menopause Market Forecast by Stage, 2023-2033 (US$ billion, AGR %)
Figure 83 Europe Menopause Market Share Forecast by Stage, 2023 & 2033 (%)
Figure 84 Europe Menopause Market Forecast by RoA, 2023-2033 (US$ billion, AGR %)
Figure 85 Europe Menopause Market Share Forecast by RoA, 2023 & 2033 (%)
Figure 86 UK Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 87 Germany Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 88 France Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 89 Italy Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 90 Spain Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 91 Russia Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 92 Rest of Europe Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 93 Asia Pacific Menopause Market Attractiveness Index
Figure 94 Asia Pacific Menopause Market by Region, 2023, 2028 & 2033 (US$ billion)
Figure 95 Asia Pacific Menopause Market Forecast by Country, 2023-2033 (US$ billion, AGR %)
Figure 96 Asia Pacific Menopause Market Share Forecast by Country, 2023 & 2033 (%)
Figure 97 Asia Pacific Menopause Market Forecast by Type, 2023-2033 (US$ billion, AGR %)
Figure 98 Asia Pacific Menopause Market Share Forecast by Type, 2023 & 2033 (%)
Figure 99 Asia Pacific Menopause Market Forecast by Distribution Channel, 2023-2033 (US$ billion, AGR %)
Figure 100 Asia Pacific Menopause Market Share Forecast by Distribution Channel, 2023 & 2033 (%)
Figure 101 Asia Pacific Menopause Market Forecast by Stage, 2023-2033 (US$ billion, AGR %)
Figure 102 Asia Pacific Menopause Market Share Forecast by Stage, 2023 & 2033 (%)
Figure 103 Asia Pacific Menopause Market Forecast by RoA, 2023-2033 (US$ billion, AGR %)
Figure 104 Asia Pacific Menopause Market Share Forecast by RoA, 2023 & 2033 (%)
Figure 105 Japan Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 106 China Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 107 India Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 108 Australia Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 109 South Korea Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 110 Rest of Asia Pacific Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 111 Latin America Menopause Market Attractiveness Index
Figure 112 Latin America Menopause Market by Region, 2022, 2027 & 2032 (US$ billion)
Figure 113 Latin America Menopause Market Forecast by Country, 2023-2033 (US$ billion, AGR %)
Figure 114 Latin America Menopause Market Share Forecast by Country, 2023 & 2033 (%)
Figure 115 Latin America Menopause Market Forecast by Type, 2023-2033 (US$ billion, AGR %)
Figure 116 Latin America Menopause Market Share Forecast by Type, 2023 & 2033 (%)
Figure 117 Latin America Menopause Market Forecast by Distribution Channel, 2023-2033 (US$ billion, AGR %)
Figure 118 Latin America Menopause Market Share Forecast by Distribution Channel, 2023 & 2033 (%)
Figure 119 Latin America Menopause Market Forecast by Stage, 2023-2033 (US$ billion, AGR %)
Figure 120 Latin America Menopause Market Share Forecast by Stage, 2023 & 2033 (%)
Figure 121 Latin America Menopause Market Forecast by RoA, 2023-2033 (US$ billion, AGR %)
Figure 122 Latin America Menopause Market Share Forecast by RoA, 2023 & 2033 (%)
Figure 123 Brazil Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 124 Mexico Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 125 Argentina Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 126 Rest of Latin America Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 127 MEA Menopause Market Attractiveness Index
Figure 128 MEA Menopause Market by Region, 2022, 2027 & 2032 (US$ billion)
Figure 129 MEA Menopause Market Forecast by Country, 2023-2033 (US$ billion, AGR %)
Figure 130 MEA Menopause Market Share Forecast by Country, 2023 & 2033 (%)
Figure 131 MEA Menopause Market Forecast by Type, 2023-2033 (US$ billion, AGR %)
Figure 132 MEA Menopause Market Share Forecast by Type, 2023 & 2033 (%)
Figure 133 MEA Menopause Market Forecast by Distribution Channel, 2023-2033 (US$ billion, AGR %)
Figure 134 MEA Menopause Market Share Forecast by Distribution Channel, 2023 & 2033 (%)
Figure 135 MEA Menopause Market Forecast by Stage, 2023-2033 (US$ billion, AGR %)
Figure 136 MEA Menopause Market Share Forecast by Stage, 2023 & 2033 (%)
Figure 137 MEA Menopause Market Forecast by RoA, 2023-2033 (US$ billion, AGR %)
Figure 138 MEA Menopause Market Share Forecast by RoA, 2023 & 2033 (%)
Figure 139 GCC Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 140 South Africa Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 141 Rest of MEA Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 142 Menopause Market: Company Share Analysis, 2021
Figure 143 Net Revenue, 2019-2021 (US$ million, AGR %)
Figure 144 Bayer: Net Revenue, 2018-2021 (US$ million, AGR %)
Figure 145 Cipla: Net Revenue, 2019-2022 (US$ million, AGR %)
Figure 146 TherapeuticsMD: Net Revenue, 2020-2021 (US$ million, AGR %)
Figure 147 Eli Lily: Net Revenue, 2019-2021 (US$ million, AGR %)
Figure 148 Emcure: Net Revenue, 2019-2021 (US$ million, AGR %)
Figure 149 Glenmark: Net Revenue, 2019-2022 (US$ million, AGR %)
Figure 150 Merck: Net Revenue, 2019-2021 (US$ million, AGR %)
Figure 151 Novartis: Net Revenue, 2020-2022 (US$ million, AGR %)
Figure 152 Novo Nordisk: Net Revenue, 2019-2022 (US$ million, AGR %)
Figure 153 Net Revenue, 2019-2021 (US$ million, AGR %)
Figure 154 Abbott: Net Revenue, 2019-2021 (US$ million, AGR %)
ページTOPに戻る
Summary
Report Details
The Menopause Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Growing Demand for Post-Menopause Drugs Owing to Rise in Geriatric Population
Some of the major forces propelling the menopause and post-menopause market include the aging population, rising awareness, technological advancements, and increasing healthcare spending drive demand for new and innovative solutions. With growing awareness about menopause and its symptoms, more women are seeking treatment options. The aging population is growing worldwide, and it is expected that the number of menopausal women will increase in the coming years. This presents a huge market opportunity for menopause drugs.
Lifestyles changes and sedentary habits have led to an increase in menopausal symptoms as women suffer from symptoms such as insomnia, erratic mood changes and hot flashes. This has led to a rise in demand for menopause drugs that can alleviate these symptoms. With new advancements in drug manufacturing and delivery methods, it is possible to create more effective and targeted menopause drugs with fewer side effects. Moreover, as healthcare expenditures increase globally, more women will have access to menopause drugs, which will drive the market further.
Misconceptions and Associated Side Effect Challenges to Hamper Industry Growth
Menopause is often stigmatized as a taboo subject and inadequately discussed. Women may feel embarrassed and uncomfortable discussing their symptoms, leading to a reluctance to seek treatment openly. Hormonal treatments for menopause may have adverse side effects, such as increased risk of cancer and heart-related problems, leading to safety concerns among patients. In addition to this, menopause products can be costly, making them inaccessible for some women. Health insurance might not be available for these products. Addressing these issues through education, product improvement, pricing strategies, and strategic marketing can significantly boost the growth of menopause products in the market.
What Questions Should You Ask before Buying a Market Research Report?
• How is the menopause market evolving?
• What is driving and restraining the menopause market?
• How will each menopause submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
• How will the market shares for each menopause submarket develop from 2023 to 2033?
• What will be the main driver for the overall market from 2023 to 2033?
• Will leading menopause markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
• Who are the leading players and what are their prospects over the forecast period?
• What are the menopause projects for these leading companies?
• How will the industry evolve during the period between 2023 and 2033? What are the implications of menopause projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the menopause market?
• Where is the menopause market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the menopause market today, and over the next 10 years:
• Our 253-page report provides 109 tables and 154 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the menopause market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Forecasts to 2033 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising menopause prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.
Segments Covered in the Report
Treatment Type Outlook
• Dietary Supplements
• OTC Pharma Products
– Hormonal
– Non-Hormonal: Anti-depressants, Others
Distribution Channel
• Retail
• Online
• Institutional Sales
Stage
• Perimenopause
• Menopause
• Post-menopause
Route of Administration
• Topical
• Oral
• Injectables
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 18 leading national markets:
North America
• U.S.
• Canada
Europe
• Germany
• UK
• France
• Spain
• Italy
• Russia
• Rest of Europe
Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific
Latin America
• Brazil
• Mexico
• Argentina
• Rest of Latin America
MEA
• GCC
• South Africa
• Rest of MEA
The report also includes profiles and for some of the leading companies in the Menopause Market, 2023 to 2033, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
• Abbott
• AbbVie Inc.
• Bayer AG
• Cipla Inc.
• Eli Lily
• Emcure
• Glenmark Pharmaceuticals Limited
• Merck
• Novartis
• Novo Nordisk
• Padagis
• Pure Encapsulations, LLC
• Teva Pharmaceuticals Limited
• Theramex
• TherapeuticsMD
Overall world revenue for Menopause Market, 2023 to 2033 in terms of value the market will surpass US$17.33 billion in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Menopause Market, 2023 to 2033 report help you?
In summary, our 250+ page report provides you with the following knowledge:
• Revenue forecasts to 2033 for Menopause Market, 2023 to 2033 Market, with forecasts for treatment type, distribution channel, stage, route of administration, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2033 for five regional and 18 key national markets – See forecasts for the Menopause Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Argentina, Germany, France, UK, Italy, Russia, China, India, Japan, South Korea and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market – including company profiles for 15 of the major companies involved in the Menopause Market, 2023 to 2033.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Menopause Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.
ページTOPに戻る
Table of Contents
Table of Contents
1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Menopause Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Market Overview
3.1 Key Findings
4 Market Overview
4.1 Key Findings
4.2 Market Dynamics
4.2.1 Market Driving Factors
4.2.1.1 The incidence of vasomotor symptoms associated with menopause is on the rise
4.2.1.2 An increase in investment in menopausal treatments
4.2.1.3 The benefits of dietary supplements are becoming increasingly apparent as more and more research is being conducted
4.2.2 Market Restraining Factors
4.2.2.1 Side effects associated with hormone therapy
4.2.2.2 Limited research and development activities
4.2.3 Market Opportunities
4.2.3.1 Start-up companies have a great opportunity
4.2.3.2 Stress and trendy lifestyles have a negative impact on women's health, creating an opportunity for menopause product manufacturer
4.3 COVID-19 Impact Analysis
4.4 Porter’s Five Forces Analysis
4.4.1 Supplier Power
4.4.2 Buyer Power
4.4.3 Competitive Rivalry
4.4.4 Threat from Substitutes
4.4.5 Threat of New Entrants
4.5 PESTLE Analysis
5 Menopause Market Analysis by Treatment
5.1 Key Findings
5.2 Treatment Segment Growth Prospects
5.3 Menopause Market Share by Type, 2023, 2028 & 2033
5.4 Dietary supplements
5.4.1 Dietary Supplements Market Forecast by Region, 2023-2033 (US$ Bn)
5.4.2 Dietary Supplements Market Share by Region, 2023-2033 (%)
5.5 OTC Pharma Products
5.5.1 OTC Pharma Products Market Forecast by Region, 2023-2033 (US$ Bn)
5.5.2 OTC Pharma Products Market Share by Region, 2023-2033 (%)
5.5.3 Hormonal
5.5.3.1 Hormonal Market Forecast by Region, 2023-2033 (US$ Bn)
5.5.3.2 Hormonal Market Share by Region, 2023-2033 (%)
5.5.4 Non-Hormonal
5.5.4.1 Non-Hormonal Market Forecast by Region, 2023-2033 (US$ Bn)
5.5.4.2 Non-Hormonal Market Share by Region, 2023-2033 (%)
5.5.5 Anti-depressants
5.5.5.1 Anti-depressants Market Forecast by Region, 2023-2033 (US$ Bn)
5.5.5.1.1 Antidepressants Market Share by Region, 2023-2033 (%)
5.5.5.2 Others
5.5.5.2.1 Others Market Forecast by Region, 2023-2033 (US$ Bn)
5.5.5.2.2 Others Market Share by Region, 2023-2033 (%)
6 Menopause Market Analysis by Distribution Channel
6.1 Key Findings
6.2 Distribution Channel Segment Growth Prospects
6.3 Menopause Market Share by Distribution Channel, 2023, 2028 & 2033
6.4 Retail
6.4.1 Retail Market Forecast by Region, 2023-2033 (US$ Bn)
6.4.2 Retail Market Share by Region, 2023-2033 (%)
6.5 Institutional Sales
6.5.1 Institutional Sales Market Forecast by Region, 2023-2033 (US$ Bn)
6.5.2 Institutional Sales Market Share by Region, 2023-2033 (%)
6.6 Online
6.6.1 Online Market Forecast by Region, 2023-2033 (US$ Bn)
6.6.2 Online Market Share by Region, 2023-2033 (%)
7 Menopause Market Analysis by Stage
7.1 Key Findings
7.2 Stage Segment Growth Prospects
7.3 Menopause Market Share by Stage, 2023, 2028 & 2033
7.4 Perimenopause
7.4.1 Perimenopause Market Forecast by Region, 2023-2033 (US$ Bn)
7.4.2 Perimenopause Market Share by Region, 2023-2033 (%)
7.5 Menopause
7.5.1 Menopause Market Forecast by Region, 2023-2033 (US$ Bn)
7.5.2 Menopause Market Share by Region, 2023-2033 (%)
7.6 Post menopause
7.6.1 Post menopause Market Forecast by Region, 2023-2033 (US$ Bn)
7.6.2 Post Menopause Market Share by Region, 2023-2033 (%)
8 Menopause Market Analysis by Route of Administration
8.1 Key Findings
8.2 Route of Administration Segment Growth Prospects
8.3 Menopause Market Share by Distribution Channel, 2023, 2028 & 2033
8.4 Topical
8.4.1 Topical Market Forecast by Region, 2023-2033 (US$ Bn)
8.4.2 Topical Market Share by Region, 2023-2033 (%)
8.5 Injectable
8.5.1 Injectable Market Forecast by Region, 2023-2033 (US$ Bn)
8.5.2 Injectable Market Share by Region, 2023-2033 (%)
8.6 Oral
8.6.1 Oral Market Forecast by Region, 2023-2033 (US$ Bn)
8.6.2 Oral Market Share by Region, 2023-2033 (%)
9 Menopause Market Analysis by Region
9.1 Key Findings
9.2 Regional Market Size Estimation and Forecast
9.3 COVID-19 Impact Analysis: Recovery Scenarios (V, U, W, L)
10 North America Menopause Market Analysis
10.1 Key Findings
10.2 North America Menopause Market Attractiveness Index
10.3 North America Menopause Market by Country, 2022, 2027 & 2032 (US$ Bn)
10.4 North America Menopause Market Size Estimation and Forecast by Country
10.5 North America Menopause Market Size Estimation and Forecast by Treatment
10.6 North America Menopause Market Size Estimation and Forecast by Distribution Channel
10.7 North America Menopause Market Size Estimation and Forecast by Stage
10.8 North America Menopause Market Size Estimation and Forecast by Route of Administration
10.9 U.S. Menopause Market Analysis
10.10 Canada Menopause Market Analysis
11 Europe Menopause Market Analysis
11.1 Key Findings
11.2 Europe Menopause Market Attractiveness Index
11.3 Europe Menopause Market by Country, 2023, 2028 & 2033 (US$ Bn)
11.4 Europe Menopause Market Size Estimation and Forecast by Country
11.5 Europe Menopause Market Size Estimation and Forecast by Treatment
11.6 Europe Menopause Market Size Estimation and Forecast by Distribution Channel
11.7 Europe Menopause Market Size Estimation and Forecast by Stage
11.8 Europe Menopause Market Size Estimation and Forecast by Route of Administration
11.9 UK Menopause Market Analysis
11.10 Germany Menopause Market Analysis
11.11 France Menopause Market Analysis
11.12 Italy Menopause Market Analysis
11.13 Spain Menopause Market Analysis
11.14 Russia Menopause Market Analysis
11.15 Rest of Europe Menopause Market Analysis
12 Asia Pacific Menopause Market Analysis
12.1 Key Findings
12.2 Asia Pacific Menopause Market Attractiveness Index
12.3 Asia Pacific Menopause Market by Country, 2023, 2028 & 2033 (US$ Bn)
12.4 Asia Pacific Menopause Market Size Estimation and Forecast by Country
12.5 Asia Pacific Menopause Market Size Estimation and Forecast by Treatment
12.6 Asia Pacific Menopause Market Size Estimation and Forecast by Distribution Channel
12.7 Asia Pacific Menopause Market Size Estimation and Forecast by Stage
12.8 Asia Pacific Menopause Market Size Estimation and Forecast by Route of Administration
12.9 Japan Menopause Market Analysis
12.10 China Menopause Market Analysis
12.11 India Menopause Market Analysis
12.12 Australia Menopause Market Analysis
12.13 South Korea Menopause Market Analysis
12.14 Rest of Asia Pacific Menopause Market Analysis
13 Latin America Menopause Market Analysis
13.1 Key Findings
13.2 Latin America Menopause Market Attractiveness Index
13.3 Latin America Menopause Market by Country, 2022, 2027 & 2032 (US$ Bn)
13.4 Latin America Menopause Market Size Estimation and Forecast by Country
13.5 Latin America Menopause Market Size Estimation and Forecast by Treatment
13.6 Latin America Menopause Market Size Estimation and Forecast by Distribution Channel
13.7 Latin America Menopause Market Size Estimation and Forecast by Stage
13.8 Latin America Menopause Market Size Estimation and Forecast by Route of Administration
13.9 Brazil Menopause Market Analysis
13.10 Mexico Menopause Market Analysis
13.11 Argentina Menopause Market Analysis
13.12 Rest of Latin America Menopause Market Analysis
14 MEA Menopause Market Analysis
14.1 Key Findings
14.2 MEA Menopause Market Attractiveness Index
14.3 MEA Menopause Market by Country, 2022, 2027 & 2032 (US$ Bn)
14.4 MEA Menopause Market Size Estimation and Forecast by Country
14.5 MEA Menopause Market Size Estimation and Forecast by Treatment
14.6 MEA Menopause Market Size Estimation and Forecast by Distribution Channel
14.7 MEA Menopause Market Size Estimation and Forecast by Stage
14.8 MEA Menopause Market Size Estimation and Forecast by Route of Administration
14.9 GCC Menopause Market Analysis
14.10 South Africa Menopause Market Analysis
14.11 Rest of MEA Menopause Market Analysis
15 Competitive Landscape
15.1 Company Share Analysis
15.2 Strategic Outlook
16 Company Profiles
16.1 Theramex
16.1.1 Company Snapshot
16.1.2 Company Overview
16.1.3 Product Benchmarking
16.1.4 Strategic Outlook
16.2 AbbVie Inc.
16.2.1 Company Snapshot
16.2.2 Company Overview
16.2.3 Financial Analysis
16.2.3.1 Net Revenue, 2019-2021
16.2.4 Product Benchmarking
16.2.5 Strategic Outlook
16.3 Bayer AG
16.3.1 Company Snapshot
16.3.2 Company Overview
16.3.3 Financial Analysis
16.3.3.1 Net Revenue, 2018-2021
16.3.4 Product Benchmarking
16.4 Cipla Inc.
16.4.1 Company Snapshot
16.4.2 Company Overview
16.4.3 Financial Analysis
16.4.3.1 Net Revenue, 2019-2022
16.4.4 Product Benchmarking
16.4.5 Strategic Outlook
16.5 TherapeuticsMD
16.5.1 Company Snapshot
16.5.2 Company Overview
16.5.3 Financial Analysis
16.5.3.1 Net Revenue, 2020-2021
16.5.4 Product Benchmarking
16.5.5 Strategic Outlook
16.6 Eli Lilly and Company
16.6.1 Company Snapshot
16.6.2 Company Overview
16.6.3 Financial Analysis
16.6.3.1 Net Revenue, 2019-2021
16.6.4 Product Benchmarking
16.7 Emcure
16.7.1 Company Snapshot
16.7.2 Company Overview
16.7.3 Financial Analysis
16.7.3.1 Net Revenue, 2019-2021
16.7.4 Product Benchmarking
16.8 Glenmark Pharmaceuticals Limited
16.8.1 Company Snapshot
16.8.2 Company Overview
16.8.3 Financial Analysis
16.8.3.1 Net Revenue, 2019-2022
16.8.4 Product Benchmarking
16.8.5 Strategic Outlook
16.9 Merck & Co., Inc.
16.9.1 Company Snapshot
16.9.2 Company Overview
16.9.3 Financial Analysis
16.9.3.1 Net Revenue, 2019-2021
16.9.4 Product Benchmarking
16.10 Novartis AG
16.10.1 Company Snapshot
16.10.2 Company Overview
16.10.3 Financial Analysis
16.10.3.1 Net Revenue, 2020-2022
16.10.4 Product Benchmarking
16.11 Novo Nordisk A/S
16.11.1 Company Snapshot
16.11.2 Company Overview
16.11.3 Financial Analysis
16.11.3.1 Net Revenue, 2019-2022
16.11.4 Product Benchmarking
16.12 Pure Encapsulations, LLC
16.12.1 Company Snapshot
16.12.2 Company Overview
16.12.3 Product Benchmarking
16.13 Padagis
16.13.1 Company Snapshot
16.13.2 Company Overview
16.13.3 Product Benchmarking
16.14 Teva Pharmaceutical Industries Ltd.
16.14.1 Company Snapshot
16.14.2 Company Overview
16.14.3 Financial Analysis
16.14.3.1 Net Revenue, 2019-2021
16.14.4 Product Benchmarking
16.14.5 Strategic Outlook
16.15 Abbott
16.15.1 Company Snapshot
16.15.2 Company Overview
16.15.3 Financial Analysis
16.15.3.1 Net Revenue, 2019-2021
16.15.4 Product Benchmarking
17 Conclusion and Recommendations
17.1 Concluding Remarks from Visiongain
17.2 Recommendations for Market Players
ページTOPに戻る
List of Tables/Graphs
List of Tables
Table 1 Menopause Market Snapshot, 2023 & 2033 (US$ Billion, CAGR %)
Table 2 Menopause Market by Region, 2023-2033 (US$ bn, AGR (%), CAGR (%)): “V” Shaped Recovery Scenario
Table 3 Menopause Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR(%)): “U” Shaped Recovery Scenario
Table 4 Menopause Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR(%)): “W” Shaped Recovery Scenario
Table 5 Menopause Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR(%)): “L” Shaped Recovery Scenario
Table 6 Dietary Supplements Market Forecast by Region, 2023-2033 (US$ billion, AGR%, CAGR %)
Table 7 OTC Pharma Products Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR %)
Table 8 Hormonal Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR %)
Table 9 Non-Hormonal Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR %)
Table 10 Anti-depressants Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR %)
Table 11 Others Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR %)
Table 12 Retail Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR %)
Table 13 Institutional Sales Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR %)
Table 14 Online Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR %)
Table 15 Perimenopause Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR %)
Table 16 Menopause Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR %)
Table 17 Post menopause Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR %)
Table 18 Topical Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR %)
Table 19 Injectable Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR %)
Table 20 Oral Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR %)
Table 21 Menopause Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR (%))
Table 22 Menopause Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR (%)): “V” Shaped Recovery Scenario
Table 23 Menopause Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR(%)): “U” Shaped Recovery Scenario
Table 24 Menopause Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR(%)): “W” Shaped Recovery Scenario
Table 25 Menopause Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR(%)): “L” Shaped Recovery Scenario
Table 26 North America Menopause Market Forecast by Country, 2023-2033 (US$ billion, AGR%, CAGR %)
Table 27 North America Menopause Market Forecast by Type, 2023-2033 (US$ billion, AGR%, CAGR %)
Table 28 North America Menopause Market Forecast by Distribution Channel, 2023-2033 (US$ billion, AGR%, CAGR%)
Table 29 North America Menopause Market Forecast by Stage, 2023-2033 (US$ billion, AGR%, CAGR%)
Table 30 North America Menopause Market Forecast by RoA, 2023-2033 (US$ billion, AGR%, CAGR%)
Table 31 U.S. Menopause Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR %)
Table 32 Canada Menopause Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR %)
Table 33 Europe Menopause Market Forecast by Country, 2023-2033 (US$ billion, AGR%, CAGR %)
Table 34 Europe Menopause Market Forecast by Type, 2023-2033 (US$ billion, AGR%, CAGR %)
Table 35 Europe Menopause Market Forecast by Distribution Channel, 2023-2033 (US$ billion, AGR%, CAGR%)
Table 36 Europe Menopause Market Forecast by Stage, 2023-2033 (US$ billion, AGR%, CAGR%)
Table 37 Europe Menopause Market Forecast by RoA, 2023-2033 (US$ billion, AGR%, CAGR%)
Table 38 UK Menopause Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR %)
Table 39 Germany Menopause Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR %)
Table 40 France Menopause Market Forecast, 2023-2033 (US$ Bn, AGR%, CAGR %)
Table 41 Italy Menopause Market Forecast, 2023-2033 (US$ Bn, AGR%, CAGR %)
Table 42 Spain Menopause Market Forecast, 2023-2033 (US$ Bn, AGR%, CAGR %)
Table 43 Russia Menopause Market Forecast, 2023-2033 (US$ Bn, AGR%, CAGR %)
Table 44 Rest of Europe Menopause Market Forecast, 2023-2033 (US$ Bn, AGR%, CAGR %)
Table 45 Asia Pacific Menopause Market Forecast by Country, 2023-2033 (US$ billion, AGR%, CAGR %)
Table 46 Asia Pacific Menopause Market Forecast by Type, 2023-2033 (US$ billion, AGR%, CAGR %)
Table 47 Asia Pacific Menopause Market Forecast by Distribution Channel, 2023-2033 (US$ billion, AGR%, CAGR%)
Table 48 Asia Pacific Menopause Market Forecast by Stage, 2023-2033 (US$ billion, AGR%, CAGR%)
Table 49 Asia Pacific Menopause Market Forecast by RoA, 2023-2033 (US$ billion, AGR%, CAGR%)
Table 50 Japan Menopause Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR %)
Table 51 China Menopause Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR%)
Table 52 India Menopause Market Forecast, 2023-2033 (US$ Bn, AGR%, CAGR %)
Table 53 Australia Menopause Market Forecast, 2023-2033 (US$ Bn, AGR%, CAGR %)
Table 54 South Korea Menopause Market Forecast, 2023-2033 (US$ Bn, AGR%, CAGR %)
Table 55 Rest of Asia Pacific Menopause Market Forecast, 2023-2033 (US$ Bn, AGR%, CAGR %)
Table 56 Latin America Menopause Market Forecast by Country, 2023-2033 (US$ billion, AGR%, CAGR %)
Table 57 Latin America Menopause Market Forecast by Type, 2023-2033 (US$ billion, AGR%, CAGR %)
Table 58 Latin America Menopause Market Forecast by Distribution Channel, 2023-2033 (US$ billion, AGR%, CAGR%)
Table 59 Latin America Menopause Market Forecast by Stage, 2023-2033 (US$ billion, AGR%, CAGR%)
Table 60 Latin America Menopause Market Forecast by RoA, 2023-2033 (US$ billion, AGR%, CAGR%)
Table 61 Brazil Menopause Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR %)
Table 62 Mexico Menopause Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR %)
Table 63 Argentina Menopause Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR %)
Table 64 Rest of Latin America Menopause Market Forecast, 2023-2033 (US$ Bn, AGR%, CAGR %)
Table 65 MEA Menopause Market Forecast by Country, 2023-2033 (US$ billion, AGR%, CAGR %)
Table 66 MEA Menopause Market Forecast by Type, 2023-2033 (US$ billion, AGR%, CAGR %)
Table 67 MEA Menopause Market Forecast by Distribution Channel, 2023-2033 (US$ billion, AGR%, CAGR%)
Table 68 MEA Menopause Market Forecast by Stage, 2023-2033 (US$ billion, AGR%, CAGR%)
Table 69 MEA Menopause Market Forecast by RoA, 2023-2033 (US$ billion, AGR%, CAGR%)
Table 70 GCC Menopause Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR %)
Table 71 South Africa Menopause Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR %)
Table 72 Rest of MEA Menopause Market Forecast, 2023-2033 (US$ Bn, AGR%, CAGR %)
Table 73 Strategic Outlook
Table 74 Theramex: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 75 Theramex: Product Benchmarking
Table 76 Theramex: Strategic Outlook
Table 77 Abbvie Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 78 AbbVie Inc.: Product Benchmarking
Table 79 AbbVie Inc.: Strategic Outlook
Table 80 Bayer AG.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 81 Bayer AG: Product Benchmarking
Table 82 Cipla Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 83 Cipla: Product Benchmarking
Table 84 Cipla: Strategic Outlook
Table 85 TherapeuticsMD.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 86 TherapeuticsMD: Product Benchmarking
Table 87 TherapeuticsMD: Strategic Outlook
Table 88 Eli Lilly and Company.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 89 Eli Lilly and Company: Product Benchmarking
Table 90 Emcure.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 91 Emcure: Product Benchmarking
Table 92 Glenmark Pharmaceuticals Limited.: Key Details, (MD, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 93 Glenmark Pharmaceuticals Limited: Product Benchmarking
Table 94 Glenmark Pharmaceuticals Limited: Strategic Outlook
Table 95 Merck & Co., Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 96 Merck & Co. Inc.: Product Benchmarking
Table 97 Novartis AG.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 98 Novartis.: Product Benchmarking
Table 99 Novo Nordisk A/S.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 100 Novo Nordisk.: Product Benchmarking
Table 101 Pure Encapsulations, LLC.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 102 Pure Encapsulations, LLC.: Product Benchmarking
Table 103 Pure Encapsulations, LLC.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 104 Padagis.: Product Benchmarking
Table 105 Teva Pharmaceuticals Limited.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 106 Teva Pharmaceuticals Limited: Product Benchmarking
Table 107 Teva Pharmaceuticals Limited: Strategic Outlook
Table 108 Abbott.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 109 Teva Pharmaceuticals Limited: Product Benchmarking
List of Figures
Figure 1 Menopause Market Segmentation
Figure 7 Menopause Market: Market Dynamics
Figure 8 COVID Impact Analysis: Menopause Market Recovery Scenarios
Figure 9 Menopause Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR (%)): “V” Shaped Recovery
Figure 10 Menopause Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR (%)): “U” Shaped Recovery
Figure 11 Menopause Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR (%)): “W” Shaped Recovery
Figure 12 Menopause Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR (%)): “L” Shaped Recovery
Figure 13 Menopause Market: Porter’s Five Forces Analysis
Figure 14 Menopause Market: PESTLE Analysis
Figure 15 Menopause Market Forecast by Type 2023, 2028, 2033 (Revenue, CAGR %)
Figure 16 Menopause Market Share Forecast by Treatment Type, 2023, 2028, 2033 (%)
Figure 17 Dietary Supplements Market Forecast by Region, 2023-2033 (US$ billion)
Figure 18 Dietary Supplements Market Share Forecast by Region, 2023-2033 (%)
Figure 19 OTC Pharma Products Market Forecast by Region, 2023-2033 (US$ billion)
Figure 20 OTC Pharma Products Market Share Forecast by Region, 2023-2033 (%)
Figure 21 Hormonal Market Forecast by Region, 2023-2033 (US$ billion)
Figure 22 Hormonal Market Share Forecast by Region, 2023-2033 (%)
Figure 23 Non-Hormonal Market Forecast by Region, 2023-2033 (US$ billion)
Figure 24 Non-Hormonal Market Share Forecast by Region, 2023-2033 (%)
Figure 25 Anti-depressants Market Forecast by Region, 2023-2033 (US$ billion)
Figure 26 Anti-depressants Market Share Forecast by Region, 2023-2033 (%)
Figure 27 Others Market Forecast by Region, 2023-2033 (US$ billion)
Figure 28 Others Market Share Forecast by Region, 2023-2033 (%)
Figure 29 Menopause Market Forecast by Distribution Channel 2023, 2028, 2033 (Revenue, CAGR %)
Figure 30 Menopause Market Share Forecast by Distribution Channels, 2023, 2028, 2033 (%)
Figure 31 Retail Market Forecast by Region, 2023-2033 (US$ billion)
Figure 32 Retail Market Share Forecast by Region, 2023-2033 (%)
Figure 33 Institutional Sales Market Forecast by Region, 2023-2033 (US$ billion)
Figure 34 Institutional Sales Market Share Forecast by Region, 2023-2033 (%)
Figure 35 Online Market Forecast by Region, 2023-2033 (US$ billion)
Figure 36 Online Market Share Forecast by Region, 2023-2033 (%)
Figure 37 Menopause Market Forecast by Stage 2023, 2028, 2033 (Revenue, CAGR %)
Figure 38 Menopause Market Share Forecast by Stage, 2023, 2028, 2033 (%)
Figure 39 Perimenopause Market Forecast by Region, 2023-2033 (US$ billion)
Figure 40 Perimenopause Market Share Forecast by Region, 2023-2033 (%)
Figure 41 Menopause Market Forecast by Region, 2023-2033 (US$ billion)
Figure 42 Menopause Institutional Sales Market Share Forecast by Region, 2023-2033 (%)
Figure 43 Post menopause Market Forecast by Region, 2023-2033 (US$ billion)
Figure 44 Post Menopause Market Share Forecast by Region, 2023-2033 (%)
Figure 45 Menopause Market Forecast by RoA 2023, 2028, 2033 (Revenue, CAGR %)
Figure 46 Menopause Market Share Forecast by RoA, 2023, 2028, 2033 (%)
Figure 47 Topical Market Forecast by Region, 2023-2033 (US$ billion)
Figure 48 Topical Market Share Forecast by Region, 2023-2033 (%)
Figure 49 Injectable Market Forecast by Region, 2023-2033 (US$ billion)
Figure 50 Injectable Market Share Forecast by Region, 2023-2033 (%)
Figure 51 Oral Market Forecast by Region, 2023-2033 (US$ billion)
Figure 52 Oral Market Share Forecast by Region, 2023-2033 (%)
Figure 53 Menopause Market Forecast by Region 2023 & 2033 (Revenue, CAGR %)
Figure 54 Menopause Market Share Forecast by Region 2023, 2028, 2033(%)
Figure 55 Menopause Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR (%))
Figure 56 Menopause Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR (%)): “V” Shaped Recovery
Figure 57 Menopause Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR (%)): “U” Shaped Recovery
Figure 58 Menopause Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR (%)): “W” Shaped Recovery
Figure 59 Menopause Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR (%)): “L” Shaped Recovery
Figure 60 North America Menopause Market Attractiveness Index
Figure 61 North America Menopause Market by Region, 2022, 2027 & 2032 (US$ billion)
Figure 62 North America Menopause Market Forecast by Country, 2023-2033 (US$ billion, AGR %)
Figure 63 North America Menopause Market Share Forecast by Country, 2023 & 2033 (%)
Figure 64 North America Menopause Market Forecast by Type, 2023-2033 (US$ billion, AGR %)
Figure 65 North America Menopause Market Share Forecast by Type, 2023 & 2033 (%)
Figure 66 North America Menopause Market Forecast by Distribution Channel, 2023-2033 (US$ billion, AGR %)
Figure 67 North America Menopause Market Share Forecast by Distribution Channel, 2023 & 2033 (%)
Figure 68 North America Menopause Market Forecast by Stage, 2023-2033 (US$ billion, AGR %)
Figure 69 North America Menopause Market Share Forecast by Stage, 2023 & 2033 (%)
Figure 70 North America Menopause Market Forecast by RoA, 2023-2033 (US$ billion, AGR %)
Figure 71 North America Menopause Market Share Forecast by RoA, 2023 & 2033 (%)
Figure 72 U.S. Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 73 Canada Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 74 Europe Menopause Market Attractiveness Index
Figure 75 Europe Menopause Market by Region, 2023, 2028 & 2033 (US$ billion)
Figure 76 Europe Menopause Market Forecast by Country, 2023-2033 (US$ billion, AGR %)
Figure 77 Europe Menopause Market Share Forecast by Country, 2023 & 2033 (%)
Figure 78 Europe Menopause Market Forecast by Type, 2023-2033 (US$ billion, AGR %)
Figure 79 Europe Menopause Market Share Forecast by Type, 2023 & 2033 (%)
Figure 80 Europe Menopause Market Forecast by Distribution Channel, 2023-2033 (US$ billion, AGR %)
Figure 81 Europe Menopause Market Share Forecast by Distribution Channel, 2023 & 2033 (%)
Figure 82 Europe Menopause Market Forecast by Stage, 2023-2033 (US$ billion, AGR %)
Figure 83 Europe Menopause Market Share Forecast by Stage, 2023 & 2033 (%)
Figure 84 Europe Menopause Market Forecast by RoA, 2023-2033 (US$ billion, AGR %)
Figure 85 Europe Menopause Market Share Forecast by RoA, 2023 & 2033 (%)
Figure 86 UK Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 87 Germany Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 88 France Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 89 Italy Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 90 Spain Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 91 Russia Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 92 Rest of Europe Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 93 Asia Pacific Menopause Market Attractiveness Index
Figure 94 Asia Pacific Menopause Market by Region, 2023, 2028 & 2033 (US$ billion)
Figure 95 Asia Pacific Menopause Market Forecast by Country, 2023-2033 (US$ billion, AGR %)
Figure 96 Asia Pacific Menopause Market Share Forecast by Country, 2023 & 2033 (%)
Figure 97 Asia Pacific Menopause Market Forecast by Type, 2023-2033 (US$ billion, AGR %)
Figure 98 Asia Pacific Menopause Market Share Forecast by Type, 2023 & 2033 (%)
Figure 99 Asia Pacific Menopause Market Forecast by Distribution Channel, 2023-2033 (US$ billion, AGR %)
Figure 100 Asia Pacific Menopause Market Share Forecast by Distribution Channel, 2023 & 2033 (%)
Figure 101 Asia Pacific Menopause Market Forecast by Stage, 2023-2033 (US$ billion, AGR %)
Figure 102 Asia Pacific Menopause Market Share Forecast by Stage, 2023 & 2033 (%)
Figure 103 Asia Pacific Menopause Market Forecast by RoA, 2023-2033 (US$ billion, AGR %)
Figure 104 Asia Pacific Menopause Market Share Forecast by RoA, 2023 & 2033 (%)
Figure 105 Japan Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 106 China Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 107 India Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 108 Australia Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 109 South Korea Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 110 Rest of Asia Pacific Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 111 Latin America Menopause Market Attractiveness Index
Figure 112 Latin America Menopause Market by Region, 2022, 2027 & 2032 (US$ billion)
Figure 113 Latin America Menopause Market Forecast by Country, 2023-2033 (US$ billion, AGR %)
Figure 114 Latin America Menopause Market Share Forecast by Country, 2023 & 2033 (%)
Figure 115 Latin America Menopause Market Forecast by Type, 2023-2033 (US$ billion, AGR %)
Figure 116 Latin America Menopause Market Share Forecast by Type, 2023 & 2033 (%)
Figure 117 Latin America Menopause Market Forecast by Distribution Channel, 2023-2033 (US$ billion, AGR %)
Figure 118 Latin America Menopause Market Share Forecast by Distribution Channel, 2023 & 2033 (%)
Figure 119 Latin America Menopause Market Forecast by Stage, 2023-2033 (US$ billion, AGR %)
Figure 120 Latin America Menopause Market Share Forecast by Stage, 2023 & 2033 (%)
Figure 121 Latin America Menopause Market Forecast by RoA, 2023-2033 (US$ billion, AGR %)
Figure 122 Latin America Menopause Market Share Forecast by RoA, 2023 & 2033 (%)
Figure 123 Brazil Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 124 Mexico Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 125 Argentina Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 126 Rest of Latin America Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 127 MEA Menopause Market Attractiveness Index
Figure 128 MEA Menopause Market by Region, 2022, 2027 & 2032 (US$ billion)
Figure 129 MEA Menopause Market Forecast by Country, 2023-2033 (US$ billion, AGR %)
Figure 130 MEA Menopause Market Share Forecast by Country, 2023 & 2033 (%)
Figure 131 MEA Menopause Market Forecast by Type, 2023-2033 (US$ billion, AGR %)
Figure 132 MEA Menopause Market Share Forecast by Type, 2023 & 2033 (%)
Figure 133 MEA Menopause Market Forecast by Distribution Channel, 2023-2033 (US$ billion, AGR %)
Figure 134 MEA Menopause Market Share Forecast by Distribution Channel, 2023 & 2033 (%)
Figure 135 MEA Menopause Market Forecast by Stage, 2023-2033 (US$ billion, AGR %)
Figure 136 MEA Menopause Market Share Forecast by Stage, 2023 & 2033 (%)
Figure 137 MEA Menopause Market Forecast by RoA, 2023-2033 (US$ billion, AGR %)
Figure 138 MEA Menopause Market Share Forecast by RoA, 2023 & 2033 (%)
Figure 139 GCC Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 140 South Africa Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 141 Rest of MEA Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 142 Menopause Market: Company Share Analysis, 2021
Figure 143 Net Revenue, 2019-2021 (US$ million, AGR %)
Figure 144 Bayer: Net Revenue, 2018-2021 (US$ million, AGR %)
Figure 145 Cipla: Net Revenue, 2019-2022 (US$ million, AGR %)
Figure 146 TherapeuticsMD: Net Revenue, 2020-2021 (US$ million, AGR %)
Figure 147 Eli Lily: Net Revenue, 2019-2021 (US$ million, AGR %)
Figure 148 Emcure: Net Revenue, 2019-2021 (US$ million, AGR %)
Figure 149 Glenmark: Net Revenue, 2019-2022 (US$ million, AGR %)
Figure 150 Merck: Net Revenue, 2019-2021 (US$ million, AGR %)
Figure 151 Novartis: Net Revenue, 2020-2022 (US$ million, AGR %)
Figure 152 Novo Nordisk: Net Revenue, 2019-2022 (US$ million, AGR %)
Figure 153 Net Revenue, 2019-2021 (US$ million, AGR %)
Figure 154 Abbott: Net Revenue, 2019-2021 (US$ million, AGR %)
ページTOPに戻る
Visiongain社の医薬・化学品分野での最新刊レポート
本レポートと同じKEY WORD（covid19）の最新刊レポート
よくあるご質問
Visiongain社はどのような調査会社ですか?
英国の調査会社ヴィジョンゲイン社（Visiongain）は、通信とエネルギーのほか、自動車や化学・医薬品、金属など、広範な市場を対象に調査を行っています。自動車市場については、市場全般に関する調査のほ... もっと見る
調査レポートの納品までの日数はどの程度ですか?
在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。
注文の手続きはどのようになっていますか?
1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。
お支払方法の方法はどのようになっていますか?
納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。
データリソース社はどのような会社ですか?
当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。
|
|
